PPT Slide
Lai et al., Clin. Infect. Dis. 36, 687-696 (2003)
Median serum alanine aminotransferase (ALT) level during 3 years of daily
lamivudine (100 mg) therapy in the subset of study participants in whom YMDD
variants developed during year 1 of therapy and persisted for ? 2 years.
ULN, upper limit of normal.